Preparation of biogenic gas vesicle nanostructures for use as contrast agents for ultrasound and MRI
Abstract
Gas vesicles (GVs) are a unique class of gas-filled protein nanostructures that are detectable at subnanomolar concentrations and whose physical properties allow them to serve as highly sensitive imaging agents for ultrasound and MRI. Here we provide a protocol for isolating GVs from native and heterologous host organisms, functionalizing these nanostructures with moieties for targeting and fluorescence, characterizing their biophysical properties and imaging them using ultrasound and MRI. GVs can be isolated from natural cyanobacterial and haloarchaeal host organisms or from Escherichia coli expressing a heterologous GV gene cluster and purified using buoyancy-assisted techniques. They can then be modified by replacing surface-bound proteins with engineered, heterologously expressed variants or through chemical conjugation, resulting in altered mechanical, surface and targeting properties. Pressurized absorbance spectroscopy is used to characterize their mechanical properties, whereas dynamic light scattering (DLS)and transmission electron microscopy (TEM) are used to determine nanoparticle size and morphology, respectively. GVs can then be imaged with ultrasound in vitro and in vivo using pulse sequences optimized for their detection versus background. They can also be imaged with hyperpolarized xenon MRI using chemical exchange saturation transfer between GV-bound and dissolved xenon—a technique currently implemented in vitro. Taking 3–8 d to prepare, these genetically encodable nanostructures enable multimodal, noninvasive biological imaging with high sensitivity and potential for molecular targeting.
Additional Information
© 2017 Macmillan Publishers Limited, part of Springer Nature. Published online 07 September 2017. This research was supported by the National Institutes of Health (R01-EB018975 to M.G.S.), DARPA (W911NF-14-1-0111 to M.G.S.), CIHR (grant no. FDN148367 to F.S.F.) and HFSP (RGP0050/2016 to M.G.S. and L.S.). A.L. is supported by an NSF graduate research fellowship (no. 1144469). A.F. is supported by an NSERC graduate fellowship. S.P.N. is supported by a Caltech Summer Undergraduate Research Fellowship. D. Maresca is supported by an HFSP Cross-Disciplinary Postdoctoral Fellowship. Research in the Shapiro laboratory is also supported by the Heritage Medical Research Institute, the Burroughs Wellcome Fund, the Pew Charitable Trust, the Sontag Foundation and the David and Lucile Packard Foundation. Research in the Schröder laboratory is also supported by the Michael J. Fox Foundation for Parkinson's Research (no. 12549) and a Koselleck Grant by the German Research Foundation (DFG; project SCHR 995/5-1). We acknowledge the Jensen Lab and the Beckman Resource Center for Electron Microscopy (EM) at the California Institute of Technology for technical guidance and for allowing us to use their resources. The EM facility is funded by the Beckman Foundation, the Gordon and Betty Moore Foundation, the Agouron Institute and the HHMI. Author Contributions: A.L., G.J.L., A.F., S.P.N. and M.G.S. conceived the manuscript layout and coordinated its writing. A.L., G.J.L., A.F., S.P.N., A.L.-G., D. Maresca, D. Malounda, R.W.B. and M.G.S developed methods for GV production, functionalization, and characterization, as well as for ultrasound imaging. M.Y., J.Y. and F.S.F. contributed methods for in vivo ultrasound imaging of GVs. M.K., C.W., L.S. and M.G.S. contributed methods for hyperpolarized xenon MRI of GVs. All authors contributed to writing the manuscript. A.L. compiled and edited the protocol and G.J.L. assembled the figures. The authors declare no competing financial interests.Attached Files
Accepted Version - nihms-978825.pdf
Supplemental Material - nprot.2017.081-S1.pdf
Supplemental Material - nprot.2017.081-S2.zip
Supplemental Material - nprot.2017.081-SF1.jpg
Files
Additional details
- Alternative title
- Preparation and Noninvasive Imaging of Biogenic Gas Vesicle Nanostructures
- PMCID
- PMC6185898
- Eprint ID
- 77531
- DOI
- 10.1038/nprot.2017.081
- Resolver ID
- CaltechAUTHORS:20170517-151452626
- NIH
- R01-EB018975
- Defense Advanced Research Projects Agency (DARPA)
- W911NF-14-1-0111
- Canadian Institutes of Health Research (CIHR)
- FDN148367
- Human Frontier Science Program
- RGP0050/2016
- NSF Graduate Research Fellowship
- DGE-1144469
- Natural Sciences and Engineering Research Council of Canada (NSERC)
- Caltech Summer Undergraduate Research Fellowship (SURF)
- Heritage Medical Research Institute
- Burroughs Wellcome Fund
- Pew Charitable Trust
- Sontag Foundation
- David and Lucile Packard Foundation
- Michael J. Fox Foundation
- 12549
- Deutsche Forschungsgemeinschaft (DFG)
- SCHR 995/5-1
- Arnold and Mabel Beckman Foundation
- Gordon and Betty Moore Foundation
- Agouron Institute
- Howard Hughes Medical Institute (HHMI)
- Created
-
2017-09-07Created from EPrint's datestamp field
- Updated
-
2022-03-22Created from EPrint's last_modified field
- Caltech groups
- Heritage Medical Research Institute, Rosen Bioengineering Center